178 related articles for article (PubMed ID: 32209188)
41. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
42. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.
Li D; Zhang Y; Xie Y; Xiang J; Zhu Y; Yang J
Cancer Gene Ther; 2013 Apr; 20(4):251-9. PubMed ID: 23470565
[TBL] [Abstract][Full Text] [Related]
43. The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients.
Liu M; Li H; Guo R; Yu X; Li Y
Clin Respir J; 2024 Feb; 18(2):e13738. PubMed ID: 38403875
[TBL] [Abstract][Full Text] [Related]
44. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD
Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907
[TBL] [Abstract][Full Text] [Related]
45. Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways.
Zhao HJ; Liu T; Mao X; Han SX; Liang RX; Hui LQ; Cao CY; You Y; Zhang LZ
Acta Pharmacol Sin; 2015 Jun; 36(6):758-68. PubMed ID: 25864648
[TBL] [Abstract][Full Text] [Related]
46. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
Li F; Zhu T; Cao B; Wang J; Liang L
Eur J Cancer; 2017 Oct; 84():184-192. PubMed ID: 28822888
[TBL] [Abstract][Full Text] [Related]
47. The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
Zhao H; Cui K; Nie F; Wang L; Brandl MB; Jin G; Li F; Mao Y; Xue Z; Rodriguez A; Chang J; Wong ST
Breast Cancer Res Treat; 2012 Jan; 131(2):425-36. PubMed ID: 21394501
[TBL] [Abstract][Full Text] [Related]
48. Sinoporphyrin Sodium-Mediated Sonodynamic Therapy Inhibits RIP3 Expression and Induces Apoptosis in the H446 Small Cell Lung Cancer Cell Line.
Shen J; Cao S; Sun X; Pan B; Cao J; Che D; Jin S; Cao Y; Tian Y; Yu Y
Cell Physiol Biochem; 2018; 51(6):2938-2954. PubMed ID: 30562734
[TBL] [Abstract][Full Text] [Related]
49. Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.
Huang Y; Chen Y; Mei Q; Chen Y; Yu S; Xia S
Oncol Rep; 2013 Jun; 29(6):2486-92. PubMed ID: 23525575
[TBL] [Abstract][Full Text] [Related]
50. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
51. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of expression profiles of some tumor growth-related genes after silencing of pleiotrophin in human small cell lung cancer H446 cells].
Yu Y; Shi MH; Xu X; Zhang ZL; Hu HC
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):405-9. PubMed ID: 20819478
[TBL] [Abstract][Full Text] [Related]
53. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
[TBL] [Abstract][Full Text] [Related]
54. Apatinib reverses alectinib resistance by targeting vascular endothelial growth factor receptor 2 and attenuating the oncogenic signaling pathway in echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene-positive lung cancer cell lines.
Chen Y; Ma G; Su C; Wu P; Wang H; Song X; Yu Q; Zeng A; Zhou S
Anticancer Drugs; 2018 Nov; 29(10):935-943. PubMed ID: 30074936
[TBL] [Abstract][Full Text] [Related]
55. Curcumin enhances the anti-cancer effects of Paris Saponin II in lung cancer cells.
Man S; Zhang L; Cui J; Yang L; Ma L; Gao W
Cell Prolif; 2018 Aug; 51(4):e12458. PubMed ID: 29608021
[TBL] [Abstract][Full Text] [Related]
56. Soluble fms-like tyrosine kinase-1-enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration.
Hao D; Li Y; Zhao G; Zhang M
Thorac Cancer; 2019 Oct; 10(10):1962-1972. PubMed ID: 31441580
[TBL] [Abstract][Full Text] [Related]
57. The human lung cancer drug resistance-related gene BC006151 regulates chemosensitivity in H446/CDDP cells.
Li S; Shi H; Ji F; Wang B; Feng Q; Feng X; Jia Z; Zhao Q; Qian G
Biol Pharm Bull; 2010; 33(8):1285-90. PubMed ID: 20686220
[TBL] [Abstract][Full Text] [Related]
58. A candidate Chinese medicine preparation-Fructus Viticis Total Flavonoids inhibits stem-like characteristics of lung cancer stem-like cells.
Cao X; Zou H; Cao J; Cui Y; Sun S; Ren K; Song Z; Li D; Quan M
BMC Complement Altern Med; 2016 Sep; 16():364. PubMed ID: 27633248
[TBL] [Abstract][Full Text] [Related]
59. Rapamycin inhibits the invasive ability of thyroid cancer cells by down-regulating the expression of VEGF-C in vitro.
Feng W; Jia S
Cell Biochem Funct; 2012 Aug; 30(6):487-91. PubMed ID: 22447639
[TBL] [Abstract][Full Text] [Related]
60. Apatinib regulates the cell proliferation and apoptosis of liver cancer by regulation of VEGFR2/STAT3 signaling.
Wen S; Shao G; Zheng J; Zeng H; Luo J; Gu D
Pathol Res Pract; 2019 Apr; 215(4):816-821. PubMed ID: 30686547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
